| Literature DB >> 33913395 |
Xiaoyan Ma1, Min Tao1, Yan Hu1, Lunxian Tang2, Jiasun Lu3, Yingfeng Shi1, Hui Chen1, Si Chen1, Yi Wang1, Binbin Cui1, Lin Du1, Weiwei Liang1, Guansen Huang1, Xun Zhou1, Andong Qiu4, Shougang Zhuang1,5, Xiujuan Zang6, Na Liu1.
Abstract
Background: The new Family-Community-Hospital (FCH) three-level comprehensive management aimed to improve the efficiency and scale of peritoneal dialysis (PD) to meet the increased population of end-stage renal disease (ESRD). Our study focused on the clinical outcomes, quality of life, and costs evaluation of this model in a multi-center and prospective cohort study.Entities:
Keywords: Peritoneal dialysis; clinical outcomes; costs evaluation; management model; quality of life
Mesh:
Year: 2021 PMID: 33913395 PMCID: PMC8901286 DOI: 10.1080/0886022X.2021.1918164
Source DB: PubMed Journal: Ren Fail ISSN: 0886-022X Impact factor: 2.606
Baseline characteristics of two PD management models.
| Total | Conventional management | FCH three-level management |
| |
|---|---|---|---|---|
| Male, | 105 (55.3) | 60(60.0) | 45(50.0) | 0.166 |
| Age (years) | 65.7 ± 13.4 | 65.5 ± 13.3 | 65.8 ± 13.6 | 0.877 |
| BMI (kg/m2) | 23.1 ± 3.2 | 23.4 ± 3.5 | 22.7 ± 2.8 | 0.126 |
| SBP(mmHg) | 147.5 ± 22.1 | 147.0 ± 22.7 | 148.0 ± 21.6 | 0.742 |
| DBP(mmHg) | 81.0 ± 12.9 | 80.2 ± 12.8 | 81.9 ± 13.1 | 0.378 |
| Education, | 0.129 | |||
| Illiteracy | 36 (19.0) | 14 (14.0) | 22 (24.7) | |
| Primary school | 60 (31.7) | 30 (30.0) | 30 (33.7) | |
| Junior high school | 66 (34.9) | 40 (40.0) | 26 (29.2) | |
| Senior high school | 21 (11.1) | 14 (14.0) | 7 (7.9) | |
| Undergraduate | 6 (3.2) | 2 (2.0) | 4 (4.5) | |
| Cause of ESRD, | <0.001 | |||
| Hypertensive nephropathy | 32 (16.8) | 26 (26.0) | 6 (6.7) | |
| Diabetic nephropathy | 51 (26.8) | 36 (36.0) | 15 (16.7) | |
| Glomerulonephritis | 95 (50.0) | 29 (29.0) | 66 (73.3) | |
| Hyperuricemic nephropathy | 3 (1.6) | 0 (0.0) | 3 (3.3) | |
| Other | 9 (4.7) | 9 (9.0) | 0 (0.0) | |
| Complication, | ||||
| Hypertension | 187 (98.4) | 98 (98.0) | 89 (98.9) | 0.624 |
| Diabetes mellitus | 78 (41.1) | 49 (49.0) | 29 (32.2) | 0.019 |
| Dyslipidemia | 78 (41.1) | 52 (52.0) | 26 (28.9) | 0.001 |
| Cardiovascular disease | 62 (32.6) | 34 (34.0) | 28 (31.1) | 0.672 |
| Cerebrovascular disease | 26 (13.7) | 18 (18.0) | 8 (8.9) | 0.068 |
| Medications n(%) | ||||
| CCB | 152 (80.0) | 78 (78.0) | 74 (82.2) | 0.468 |
| ARB/ACEI | 126 (66.3) | 68 (68.0) | 58 (64.4) | 0.605 |
| Lipid-lowering medications | 67 (35.3) | 44 (44.0) | 23 (25.6) | 0.008 |
| Anti-diabetic medications | 10 (5.3) | 4 (4.0) | 6 (6.7) | 0.430 |
| Insulin | 47 (24.7) | 31 (31.0) | 16 (17.8) | 0.035 |
| Antiplatelet medications | 47 (24.7) | 29 (29.0) | 18 (20.0) | 0.151 |
| Calcitriol | 43 (22.6) | 20 (20) | 23 (25.6) | 0.361 |
PD: peritoneal dialysis; FCH: Family-Community-Hospital; BMI: body mass index; SBP: systolic blood pressure, DBP: diastolic blood pressure; ESRD: end-stage renal disease; CCB: calcium channel blocker; ARB/ACEI: angiotensin receptor blocker/angiotensin converting enzyme inhibitors. Other reasons for ESRD included IgA nephropathy, polycystic kidney, obstructive nephropathy.
Outcomes of PD patients under different management models.
| Total | Conventional management | FCH three-level management |
| |
|---|---|---|---|---|
| Duration on PD (months) | 43.5 (26.0–64.3) | 41.0 (23.8–61.8) | 45.5 (26.8–68.0) | 0.606 |
| Dropout by cause, | ||||
| Overall | 91 (47.9) | 51 (51.0) | 40 (44.4) | 0.366 |
| Death | 69 (75.8) | 38 (74.5) | 31 (77.5) | |
| Kidney transplantation | 3 (3.3) | 2 (3.9) | 1 (2.5) | |
| Transfer to hemodialysis | 16 (17.6) | 9 (17.6) | 7 (17.5) | |
| Loss to follow-up | 3 (3.3) | 2 (3.9) | 1 (2.5) | |
| Cause of death, | 0.757 | |||
| Cerebrovascular disease | 9 (13.0) | 7 (18.4) | 2 (6.5) | |
| Cardiovascular disease | 11 (15.9) | 5 (13.2) | 6 (19.4) | |
| Infection | 16 (23.2) | 8 (21.1) | 8 (25.8) | |
| Electrolyte disorder | 5 (7.2) | 3 (7.9) | 2 (6.5) | |
| Cachexia | 5 (7.2) | 3 (7.9) | 2 (6.5) | |
| Other | 23 (33.3) | 12 (31.6) | 11 (35.5) | |
| Tunnel infection, | 8 (4.2) | 4 (4.0) | 4 (4.4) | 0.879 |
| Peritonitis rate (per patient-year) | 0.19 | 0.21 | 0.16 | 0.965 |
| Time to 1st peritonitis episode (month) | 13.0 (8–24.0) | 16.5 (8.3–23.0) | 12.0 (7.0–26.8.0) | 0.734 |
| Peritonitis episodes, | 0.116 | |||
| 0 | 98 (51.6) | 52 (52.0) | 46 (51.1) | |
| 1 | 61 (32.1) | 31 (31.0) | 30 (33.3) | |
| 2 | 17 (8.9) | 6 (6.0) | 11 (12.2) | |
| ≥3 | 14 (7.4) | 11 (11.0) | 3 (3.3) |
PD: peritoneal dialysis; FCH: Family-Community-Hospital; Other reasons for death included hypoglycemia, gastrointestinal hemorrhage, fracture, suicide, Alzheimer’s Disease.
Figure 1.Patient and technique survival in PD patients under two management models. (A) Patient survival. (B) Technique survival. PD: peritoneal dialysis; FCH: Family-Community-Hospital.
Figure 2.Renal and peritoneal functions in PD patients under two management models. (A) Serum creatinine. (B) Blood urea nitrogen. (C) Total Kt/V. (D) Peritoneal Kt/V. PD: peritoneal dialysis; FCH: Family-Community-Hospital; Kt/V: the clearance rate of urea nitrogen.
Figure 3.Serum protein and lipid levels in PD patients under two management models. (A) Hemoglobin. (B) Serum albumin. (C) Total cholesterol. (D) Triglyceride. PD: peritoneal dialysis; FCH: Family-Community-Hospital.
Figure 4.Serum calcium and phosphorus levels in PD patients under two management models. (A) PTH. (B) Serum calcium. (C) Serum phosphorus. PD: peritoneal dialysis; PTH: parathyroid hormone. FCH: Family-Community-Hospital.
The score of health survey in two PD management models.
| Conventional management | FCH three-level management |
| |
|---|---|---|---|
| Physical functioning | 58.7 ± 13.9 | 61.2 ± 14.9 | 0.385 |
| Role-physical | 65.3 ± 15.2 | 68.0 ± 15.2 | 0.379 |
| Bodily pain | 76.3 ± 22.2 | 74.8 ± 28.6 | 0.780 |
| General health | 39.4 ± 13.1 | 41.2 ± 16.2 | 0.556 |
| Vitality | 44.6 ± 18.2 | 45.9 ± 17.1 | 0.713 |
| Social functioning | 48.0 ± 20.1 | 58.8 ± 18.3 | 0.006 |
| Role-emotional | 55.1 ± 23.1 | 66.0 ± 26.5 | 0.032 |
| Mental health | 46.5 ± 12.7 | 52.4 ± 14.9 | 0.036 |
PD: peritoneal dialysis; FCH: Family-Community-Hospital.
The annual expenses of two PD management models.
| Conventional management | FCH three-level management |
| |
|---|---|---|---|
| Hospitalization frequency ( | 3.4 (2.0–5.0) | 2.6 (1.6–4.0) | 0.009 |
| Outpatient visits ( | 49.5 (35.8–70.4) | 41.8 (31.7–49.7) | 0.001 |
| Hospitalization expenses (CNY) | 44 995.8 (25 057.8–83 557.8) | 32 978.6 (16 764.1–50 926.9) | 0.005 |
| Outpatient expenses (CNY) | 60 299.0 (45 025.6–76 704.2) | 54 492.3 (46 027.5–61 640.3) | 0.026 |
| Total medical expenses (CNY) | 108 108.5 (75 204.3–154 539.8) | 85 872.7 (70 554.9–107 299.5) | 0.003 |
| Transport expenses (CNY) | 1 538.0 (623.6–2 567.0) | 951.6 (442.6–1 783.0) | 0.006 |
| Distance (kilometer) | 9.1 (3.7–15.8) | 11.0 (3.5–14.3) | 0.353 |
PD: peritoneal dialysis; FCH: Family-Community-Hospital. CNY: China Yuan. One dollar is equal to 6.4489 CNY. Hospitalization expenses and visits only refer to PD related admissions in central hospital. The community does not have a PD inpatient ward. Outpatient expenses and visits refer to both community clinic and central hospital clinic. Transport expenses refer to the costs only payed for commuting to central hospital. Distance refers to the distance from home to central hospital.
Figure 5.The annual medical visits and costs of two management models. (A) Hospitalization frequency. (B) Outpatient visits. (C) Total medical costs. (D) Hospitalization costs. (E) Outpatient costs. (F) Transport costs. Hospitalization costs and visits only refer to PD related admissions in central hospital. Community do not have PD inpatient ward. Outpatient costs and visits refer to both community clinic and central hospital clinic. Transport costs refer to the costs only payed for commuting to central hospital. PD: peritoneal dialysis; FCH: Family-Community-Hospital; CNY: China Yuan. One dollar was equal to 6.7606 CNY (5 year average exchange rate, from 2016 to 2020).